Presented in part at the 70th Annual Scientific Meeting of the American College of Rheumatology, Washington, DC, November 2006, and at the 13th International Vasculitis Meeting and ANCA Workshop, Cancun, Mexico, April 2007.
Giant Cell Arteritis
Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis†
Version of Record online: 28 MAY 2010
Copyright © 2010 by the American College of Rheumatology
Arthritis Care & Research
Volume 62, Issue 6, pages 835–841, June 2010
How to Cite
García-Martínez, A., Hernández-Rodríguez, J., Espígol-Frigolé, G., Prieto-González, S., Butjosa, M., Segarra, M., Lozano, E. and Cid, M. C. (2010), Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis. Arthritis Care Res, 62: 835–841. doi: 10.1002/acr.20043
- Issue online: 28 MAY 2010
- Version of Record online: 28 MAY 2010
- Manuscript Accepted: 22 JAN 2010
- Manuscript Received: 20 AUG 2009
- Ministerio de Ciencia y Tecnología and Fondo Europeo de Desarrollo Regional. Grant Number: SAF 08/04328
- Research award from the Hospital Clínic
- Fundació Pedro Pons
- Instituto de Salud Carlos III
- 2Incidence and predictors of large-artery complications (aortic aneurysm, aortic dissection, and/or large artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48: 3522–31., , , , .
- 9Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003; 107: 2428–34., , , , , , et al.
- 24Proinflammatory functions of vascular smooth muscle cells (VSMC) in giant cell arteritis (GCA) [abstract]. Arthritis Rheum 2008; 58 Suppl: S928–9., , , , , , et al.
- 38Baseline osteopenia is associated with subsequent bone loss and fractures in glucocorticosteroid-treated patients with giant-cell arteritis (GCA) receiving calcium and vitamin D supplements [abstract]. Arthritis Rheum 2000; 43 Suppl: S1793., , , , , , et al.